Marketing efforts to uninsured youth ramp up
The so-called "young invincibles" are so important to the success of the Affordable Care Act that supporters and detractors are spending millions to reach them.
The so-called "young invincibles" are so important to the success of the Affordable Care Act that supporters and detractors are spending millions to reach them.
The Supreme Court has thrown a hitch into President Barack Obama's new health care law by blocking a requirement that some religion-affiliated organizations provide health insurance that includes birth control.
Jonathan S. Nalli, 39, has led Porter Health System in Valparaiso since 2007. He will take over the 22-hospital St. Vincent system on Feb. 1.
IU Health has decided to still give patients the same “in network” co-pays and deductibles that UnitedHealthcare had negotiated under the expiring contracts, keeping patients’ costs the same until a new deal is reached.
The windfall comes at a critical moment for health care reform, which becomes “real” for many Americans on Jan. 1 as coverage through the insurance exchanges and key patient protections kick in.
When Joe Swedish was named the next CEO of WellPoint Inc., investors frowned. At first.
The pace of rule-making and decision-making was feverish in the year leading up to the Jan. 1, 2014, implementation of Obamacare.
After suffering for years with decrepit heating and ventilating systems, Wishard, the busiest hospital in the state, finally got a new home. And a new name.
The deadline to enroll in plans that begin Jan. 1 now is midnight Tuesday for most of the U.S. On Monday, healthcare.gov fielded nearly 50,000 simultaneous visitors, triggering a queuing system.
Laura Noblitt is a Zionsville-based occupational therapist with 25 years of experience in geriatric rehabilitation. She has spent half a decade riding shotgun with elderly drivers in central Indiana, determining whether it’s safe for them to stay behind the wheel.
Eli Lilly and Co., Pfizer Inc., Sanofi and other large drugmakers will keep paying doctors to give talks about their products, leaving GlaxoSmithKline Plc alone for now in its decision to halt such compensation.
Consumers who enroll in health plans through the new U.S. exchanges will get 10 extra days to pay their first premiums and still gain coverage effective Jan. 1, an insurance company trade group said Wednesday.
Fifteen years after Pfizer Inc.’s Viagra changed the sexual equation for older men, the blockbuster impotence drug is set to become available in a less expensive generic form as early as 2017.
Even though St. Louis-based Ascension Health cut nearly 900 jobs this year from its Indianapolis-based hospital subsidiary, St. Vincent Health, it wants to add 549 more to its service center here by 2016.
There's more disappointing news about multivitamins: Two major studies found popping the pills didn't protect aging men's brains or help heart attack survivors.
The facility in Columbus would be the first of its kind for the company. Should the concept prove successful, Cummins will consider similar arrangements in other areas with Cummins plants, said Dr. Dexter Shurney, chief medical officer for Cummins.
Eskenazi Health leadership’s desire to connect the diversity of its hospital’s population through a healing park drew in a landscape architect firm that is not only one of the top in the country, but also one of the hottest architecture firms in the world.
Tom Fischer, the chief financial and chief operating officer of Community Health Network, departed suddenly this month. Sources with knowledge of the situation described Fischer’s exit as a firing. But a Community spokeswoman said Fischer resigned in a private meeting with Community CEO Bryan Mills.
Since 1998, there have been more than 100 attempts to develop an Alzheimer’s treatment, and all have failed. Such a product may generate as much as $5 billion annually for Merck, according to analysts
Cymbalta is Eli Lilly and Co. Inc.'s best-selling drug and posted 2012 sales of $4.7 billion, making it the fifth-highest selling medication in the world. The drug's patent expired Wednesday.